Avendus Future Leaders Fund and SBI Life Insurance have collectively invested ₹300 crore in Aragen Life Sciences, acquiring a 2.5% stake in...

Quadria Capital, an Asia healthcare-focused private equity firm, has successfully raised $1.07 billion for its third fund, surpassing its i...

India's contract drug makers are seeking government support to remove regulatory hurdles and speed up raw material import clearances. With ...

In this pre-IPO round, Quadria will acquire the minority stake in Aragen, at an approximate valuation of $1.4 bn, primarily through a fresh...

Quadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...

Reliance Retail's Isha Ambani and Parita Parekh from Toddle are the youngest women in the inaugural 2024 Hurun India Under35s list. The lis...

Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...

Aragen Life Sciences plans to invest Rs 2000 crore in its Hyderabad plant for expansion, creating 1,500 new jobs. The expansion is focused ...

ChrysCapital's proposed investment will give an exit to Mahindra Partners, the PE arm of Mahindra & Mahindra, which owns about 32% stake in...

China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low ...

Private equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...

The platform -- Equal, is built in partnership with government-owned DigiLocker and public digital infrastructure India Stack.

FDI inflows in the research and development sector have increased to USD 343.64 million in 2021 against USD 55.77 million in 2020, the comm...

Aragen Life Sciences signs a definitive agreement to acquire Pune-based Intox Pvt. Ltd. The Hyderabad-based Aragen, which was formerly call...

Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...

The other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.

In this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...